Latest influenza A Stories
MDRNA, Inc. (Nasdaq: MRNA) announced today positive in vivo efficacy data on its proprietary RNAi-based therapeutic for the treatment of multiple strains of influenza A virus in animal models.
Each winter, strains of influenza A virus infect North Americans, causing an average of 36,000 deaths. Now, researchers say the virus comes from a viral reservoir somewhere in the tropics, settling a key debate on the source of each season's infection.
The exchange of genetic material between two closely related strains of the influenza A virus may have caused the 1947 and 1951 human flu epidemics, according to biologists.
NEW YORK (Reuters Health) - During outbreaks of influenza A, treating children with the antiviral drug amantadine is likely to be a cost-effective measure if treatment begins within 48 hours of symptom onset, especially if it allows quicker return to school and parents' return to work, investigators report.
- A hairdresser.